| http://www.w3.org/ns/prov#value | - Agent: Glaxosmithkline C/o Foley & Lardner LLP20090197857 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes: The present invention provides novel substituted amino-azetidines that are useful as cannabinoid receptor antagonists/inverse agonists and pharmaceutical compositions thereof and methods of using the same for treating
|
